COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Highlights
-
- First COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease.
- Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.
- Significantly reduced hospitalisation rates in the treatment group.
- Reduced mortality rates in the treatment group.